All In Biotech

Drug Trial Radar · NCT03339128

Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Eluxadoline in Pediatric Participants (Age 6 to 17 Years) With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 272 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

272

Actual

Start

Nov 15, 2017

Primary completion

Aug 17, 2026

Study completion Aug 17, 2026

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Nov 13, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objectives of this study are to explore the therapeutic effect of eluxadoline in treating irritable bowel syndrome with diarrhea (IBS-D) in pediatric participants 6-17 years of age, to evaluate the pharmacokinetics of eluxadoline in pediatric participants with IBS-D, and to evaluate the safety and tolerability of eluxadoline in pediatric participants with IBS-D. Enrollment of 12-17 years old age group is closed, enrollment of the 6-11 years old age group will continue.

Conditions

  • Irritable Bowel Syndrome

Interventions

  • EluxadolineDrug

    Oral tablets

  • PlaceboDrug

    Oral tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in stool consistency averaged over the 4-week Treatment PeriodTime frame: Baseline (2 Weeks prior to randomization) to Week 4

Locations

46 sites in 9 countries. Site status is shown where the registry gives one.

  • HealthStar Research of Hot Springs PLLC /ID# 234609

    Hot Springs, Arkansas

  • Applied Research Center of Arkansas /ID# 238070

    Little Rock, Arkansas

  • Kindred Medical Institute, LLC /ID# 237368

    Corona, California

  • Duplicate_VVCRD Research /ID# 234606

    Garden Grove, California

  • Duplicate_Center for Clinical Trials LLC /ID# 234630

    Paramount, California

  • Sunrise Research Institute /ID# 237382

    Miami, Florida

  • South Miami Medical & Research Group Inc. /ID# 234655

    Miami, Florida

  • Valencia Medical & Research Center /ID# 234672

    Miami, Florida

  • Florida Research Center, Inc. /ID# 236514

    Miami, Florida

  • Duplicate_Wellness Clinical Research /ID# 237401

    Miami Lakes, Florida

  • Global Research Associates /ID# 234646

    Atlanta, Georgia

  • Children's Ctr Digestive, US /ID# 237575

    Atlanta, Georgia

  • Sleep Care Research Institute d/b/a Clinical Research Institute /ID# 236343

    Stockbridge, Georgia

  • Advocate Children's Hospital-Park Ridge /ID# 235388

    Park Ridge, Illinois

  • Indiana University Health Riley Hospital for Children /ID# 235400

    Indianapolis, Indiana

  • Michael W. Simon, MD, PSC /ID# 236517

    Lexington, Kentucky

  • Frederick County Pediatrics /ID# 234519

    New Market, Maryland

  • MNGI Digestive Health, P. A. /ID# 238057

    Minneapolis, Minnesota

  • Celen Medical Group Corp - Marlton /ID# 234922

    Marlton, New Jersey

  • IPS Research Company /ID# 237672

    Oklahoma City, Oklahoma

  • Children's Hospital of Philadelphia - Main /ID# 234313

    Philadelphia, Pennsylvania

  • Preferred Primary Care Physicians, Inc. /ID# 236436

    Pittsburgh, Pennsylvania

  • Cook Children's Med. Center /ID# 237537

    Fort Worth, Texas

  • Texas Children's Hospital /ID# 238304

    Houston, Texas

  • Sun Research Institute /ID# 236933

    San Antonio, Texas

  • West Virginia University Hospitals /ID# 256841

    Morgantown, West Virginia

  • MHATSv.Ivan Rilski /ID# 235399

    Kozloduy, Bulgaria

  • University Hospital Plovdiv /ID# 235450

    Plovdiv, Bulgaria

  • Medical center 1 Sevlievo /ID# 237473

    Sevlievo, Gabrovo, Bulgaria

  • Duplicate_Edmonton Clinic Health Academy (ECHA) /ID# 234917

    Edmonton, Canada

  • Manitoba Institute of Child Health /ID# 235448

    Winnepeg, Canada

  • HELIOS Klinikum Wuppertal /ID# 237322

    Wuppertal, Germany

  • Eszak-Kozep-budai Centrum, Uj Szent Janos Korhaz /ID# 236993

    Budapest, Hungary

  • Soproni Erzsebet Oktato Korhaz es Rehabilitacios Intezet /ID# 237341

    Sopron, Hungary

  • Vita Verum Medical Bt. /ID# 234321

    Székesfehérvár, Hungary

  • Duplicate_Academisch Medisch Centrum /ID# 237117

    Amsterdam, North Holland, Netherlands

  • Specjalistyczne Gabinety Sp. z o.o. /ID# 236347

    Krakow, Lesser Poland Voivodeship, Poland

  • Instytut Centrum Zdrowia Matki Polki /ID# 237438

    Lodz, Łódź Voivodeship, Poland

  • Centrum Zdrowia MDM /ID# 237269

    Warsaw, Masovian Voivodeship, Poland

  • Duplicate_Instytut Pomnik - Centrum Zdrowia Dziecka /ID# 234311

    Warsaw, Masovian Voivodeship, Poland

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.